Pharma BD Deal Intelligence
Shire Pharmaceuticals Group plc / Transkaryotic Therapies, Inc. (TKT)
2005 · Acquisition/Merger · $1.6B · Complete
Announcement Sentiment
38
Skeptical
Shire agrees to acquire TKT for $37/share cash (~$1.6B). Adds Replagal (Fabry) and Dynepo to rare disease portfolio. Shareholders approved July 2005.
Key facts
- Announced Apr 21, 2005
- Closed Jul 27, 2005
- Deal value $1.6B
- Deal type Acquisition/Merger
See the full interactive analysis, sources & comparables →
← Browse all deals ·
How we score deals